Combinational Therpies and Drugs for Diabetes Mellitus Type I and Type II

Authors

  • Sivasankari S.1, Kumaravel S.2, Govardhanan K.3, Ganesh Kumar4

DOI:

https://doi.org/10.37506/mlu.v20i4.2199

Keywords:

Diabetes, therapies, drugs, mellitus.

Abstract

Diabetes mellitus is a metabolic disorder causes changes in the blood glucose level either it can be elevated or
lowered. These are classified into two type insulin dependent and insulin non-dependent. The basic treatment
provided for diabetic patients are insulin therapy it has been clinically proven but this is not the only solution
to cure diabetes. Metformin is widely used medicine for patients. Glucose lowering therapy is applicable
for patients with severe hyperglycemia, hepatic and renal related diseases. The therapeutic applications such
as The therapeutic medicines exenatide and to induce the insulin secretion and also liraglutide helps people
with insulin. Other therapeutic compounds heals the defects of beta-cells secretion are compensated with
the use of stitagliptin to inhibit the dipeptidyl peptidase-4 (DPP-4) enzyme, and increases the the function
of Islets cells. This article further discusses about the combinational therapies available for the diabetic
patients.

Author Biography

  • Sivasankari S.1, Kumaravel S.2, Govardhanan K.3, Ganesh Kumar4

    1Professor, Department of Microbiology, Meenakshi Medical College Hospital and Research Institute, Enathur,
    Kanchipuram, Tamilnadu, India, 2Professor & HOD, Department of Dermatology, Meenakshi Medical College
    Hospital and Research Institute, Enathur, Kanchipuram, Tamilnadu, India, 3Professor, Department of General
    Surgery, Meenakshi Medical College Hospital and Research Institute, Enathur, Kanchipuram, Tamilnadu, India,
    4Assistant Professor, Department of Pharmacology, Meenakshi Medical College Hospital and Research Institute,
    Enathur, Kanchipuram, Tamilnadu, India

Downloads

Published

2020-11-18

How to Cite

Combinational Therpies and Drugs for Diabetes Mellitus Type I and Type II. (2020). Medico Legal Update, 20(4), 2348-2352. https://doi.org/10.37506/mlu.v20i4.2199